AMDOCAL

This brand name is authorized in Nigeria. It is also authorized in Hong Kong SAR China.

Active ingredients

The drug AMDOCAL contains one active pharmaceutical ingredient (API):

1
UNII 864V2Q084H - AMLODIPINE BESYLATE
 

Amlodipine is a calcium ion influx inhibitor of the dihydropyridine group (slow channel blocker or calcium ion antagonist) and inhibits the transmembrane influx of calcium ions into cardiac and vascular smooth muscle.

 
Read more about Amlodipine

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
A4-2906 Tablet Amdocal 10 Tablet TAB 10 mg 310 Amdocal 10 Tablet AMLODIPINE 10mg Amlodipine Besilate BP eqv. to Amlodipine 10mg, Microcrystalline cellulose 132.5mg. Brilliant Blue 0.04mg, Anhydrous Dibasic calcium Phosphate 91.58mg, Sodium starch Glycolate 10mg & Magnesium stearate 2mg A4-2906 Drugs Imported Products 310 Prescription Only Medicine (POM) 19/12/2019 PHARMADEAL NIGERIA LIMITED, 1A Oyewole Oshodi street, Ilupeju. 8038510048 ccnwabisi2010@yahoo.com Beximco Pharmaceuticals Limited, 126, Kathaldia, Auchpara, Tongi-Gazipur, Bangladesh, Bangladesh 26/04/2023
A4-3488 Tablet Amdocal 5 Tablet TAB 5 mg 510,715 13 RNW-PP-284960 Amdocal 5 AMLODIPINE 5MG Amlodipine besilate BP 6.940mg, Microcrystalline cellulose BP 151.060mg, Dibasic calcium phosphate USP 80.000mg, Sodium starch glycolate BP 10.000mg & Magnesium stearate BP 2.000mg A4-3488 Drugs Imported Products 510,715 Prescription Only Medicine (POM) 10/6/2022 PHARMADEAL NIGERIA LIMITED, 1A Oyewole Oshodi street, Ilupeju. 8038510048 ccnwabisi2010@yahoo.com Beximco Pharmaceutical Ltd, 126, Kathaldia, Auchpara, Tongi, Gazipur, Bangladesh, Bangladesh 06/07/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
C08CA01 Amlodipine C Cardiovascular system → C08 Calcium channel blockers → C08C Selective calcium channel blockers with mainly vascular effects → C08CA Dihydropyridine derivatives
Discover more medicines within C08CA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
HK Department of Health Drug Office 55421, 55424
NG Registered Drug Product Database A4-2906, A4-3488

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.